학술논문
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): Overall survival results of a phase 3 randomised trial
Document Type
Article
Author
Oza, A.M.; Cook, A.D.; Embleton, A.; Farrelly, L.; Kaplan, R.; Parmar, M.K.B.; Pfisterer, J.; Ledermann, J.A.; Pujade-Lauraine, E.; Kristensen, G.; Carey, M.S.; Beale, P.; Cervantes, A.; Park-Simon, T.-W.; Rustin, G.; Joly, F.; Mirza, M.R.; Plante, M.; Quinn, M.; Poveda, A.; Jayson, G.C.; Stark, D.; Perren, T.J.; Swart, A.M.
Source
In: The Lancet Oncology . (The Lancet Oncology, 1 August 2015, 16(8):928-936)
Subject
Language
English
ISSN
14745488
14702045
14702045